HeartSciences Inc.
HSCS
$3.75
$0.3710.95%
NASDAQ
04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | |
---|---|---|---|---|---|
Net Income | 17.43% | -21.77% | -1.52% | -11.13% | -12.31% |
Total Depreciation and Amortization | 7.93% | -15.70% | 3.30% | 11.00% | 26.05% |
Total Amortization of Deferred Charges | 0.00% | 66.67% | -- | -- | -100.00% |
Total Other Non-Cash Items | 368.07% | 22.87% | -30.96% | -63.79% | -10.40% |
Change in Net Operating Assets | -85.34% | 394.18% | -278.43% | -206.39% | 108.70% |
Cash from Operations | 1.82% | 25.81% | -8.17% | -28.03% | 24.95% |
Capital Expenditure | -- | 100.00% | -- | -- | -454.55% |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | 50.32% | -481.48% | -237.50% | 96.08% | 49.50% |
Cash from Investing | 50.32% | -170.69% | -625.00% | 98.84% | -40.65% |
Total Debt Issued | -- | -100.00% | -- | -- | -- |
Total Debt Repaid | 0.00% | -2.15% | -33.78% | 29.59% | -46.83% |
Issuance of Common Stock | -31.86% | 107.60% | -79.94% | 33.80% | -95.08% |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -- | -- | -- | -- |
Cash from Financing | -44.51% | -90.52% | 244.70% | 46.30% | -95.87% |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -2.94% | -405.94% | 80.40% | -15.69% | -118.19% |